MiR-874-3p plays a protective role in intervertebral disc degeneration by suppressing MMP2 and MMP3

Intervertebral disc degeneration (IDD) is a spinal degenerative disease and one of the most important causes of musculoskeletal disability. Matrix metalloproteinase (MMP)-mediated extracellular matrix degradation is the core process of IDD. The regulators of MMPs in the intervertebral disc are still not fully known. In this study, using quantitative reverse transcription PCR, luciferase reporter assay, Western blotting, immunofluorescence, flow cytometry, and Cell Counting Kit-8 assay, we found that the miR-874-3p expression level was significantly decreased in IDD patients. MiR-874-3p could target and repress MMP2 and MMP3 expression in nucleus pulposus cells. These results could improve the understanding of IDD and provide a possible diagnostic marker and treatment candidate for IDD. The miR-874-3p/MMP2/MMP3 axis might also provide direction for future cancer and inflammation investigations.

Automated summary

The study found that the expression level of miR-874-3p was significantly decreased in IDD patients, and it could target and repress MMP2 and MMP3 expression, potentially providing a diagnostic marker and treatment candidate for IDD, as well as direction for future investigations on cancer and inflammation.